Login / Signup

Two cases of MT-ND5 -related mitochondrial disorder misdiagnosed as seronegative neuromyelitis optica spectrum disorder.

Sophie R WilkinsAmy W YuConnolly SteigerwaldKurenai TanjiAlejandro D IglesiasMichio HiranoIlya KisterClaire S RileyNicolas J Abreu
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease primarily affecting the optic nerves and spinal cord, which is usually associated with anti-aquaporin-4 antibodies. Here, we present two individuals who were negative for anti-aquaporin-4 antibodies and were initially diagnosed with seronegative NMOSD. Each patient's clinical course and radiographic features raised suspicion for an alternative disease process. Both individuals were found to have pathogenic variants of MT-ND5 , encoding subunit 5 of mitochondrial complex I, ultimately leading to a revised diagnosis of a primary mitochondrial disorder. These cases illustrate the importance of biochemical and genetic testing in atypical cases of NMOSD.
Keyphrases
  • spectrum disorder
  • oxidative stress
  • spinal cord
  • multiple sclerosis
  • spinal cord injury
  • copy number
  • case report
  • neuropathic pain
  • optical coherence tomography